Ark Genomic Revolution UCITS ETF (SWX:ARKG)
Switzerland · Delayed Price · Currency is CHF 7.90
-0.15 (-1.91%)
At close: Sep 23, 2026
SWX:ARKG Holdings Information
SWX:ARKG is an equity ETF with a total of 32 individual holdings. The top holdings are Twist Bioscience stock at 9.36%, Tempus AI at 8.95%, 10x Genomics at 7.30%, CRISPR Therapeutics AG at 5.49%, and Absci at 5.24%.
Total Holdings
32
Top 10 Percentage
58.71%
Asset Class
Equity
ETF Category
Theme
Assets
89.66M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 9.36% |
| 2 | TEM | Tempus AI, Inc. | 8.95% |
| 3 | TXG | 10x Genomics, Inc. | 7.30% |
| 4 | CRSP | CRISPR Therapeutics AG | 5.49% |
| 5 | ABSI | Absci Corporation | 5.24% |
| 6 | NTRA | Natera, Inc. | 4.77% |
| 7 | CDNA | CareDx, Inc. | 4.70% |
| 8 | ILMN | Illumina, Inc. | 4.58% |
| 9 | PSNL | Personalis, Inc. | 4.40% |
| 10 | LLY | Eli Lilly and Company | 3.92% |
| 11 | CMPS | COMPASS Pathways plc | 3.48% |
| 12 | GH | Guardant Health, Inc. | 3.14% |
| 13 | BEAM | Beam Therapeutics Inc. | 3.07% |
| 14 | SDGR | Schrödinger, Inc. | 2.90% |
| 15 | NTLA | Intellia Therapeutics, Inc. | 2.81% |
| 16 | RXRX | Recursion Pharmaceuticals, Inc. | 2.77% |
| 17 | BFLY | Butterfly Network, Inc. | 2.55% |
| 18 | NRIX | Nurix Therapeutics, Inc. | 2.33% |
| 19 | WGS | GeneDx Holdings Corp. | 2.22% |
| 20 | VCYT | Veracyte, Inc. | 2.12% |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 1.95% |
| 22 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.84% |
| 23 | ALMR | Alamar Biosciences, Inc. | 1.62% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 1.58% |
| 25 | PRME | Prime Medicine, Inc. | 1.26% |
As of Sep 22, 2026